Literature DB >> 2415591

Cell surface molecular changes on the activation of human thymocytes.

F Sanchez-Madrid, M L Toribio, F Gambón, M O de Landazuri.   

Abstract

The changes in the expression of antigen molecules on the cell surface membranes of uncultured (nonactivated) and activated human thymocytes have been studied by flow cytometry and immunoprecipitation techniques. Nonactivated thymocytes do not have the phenotypic profile of a resting population because they express cell proliferation molecules such as the transferrin receptor and the 4F2 antigens (mainly the 100,000 dalton subunit). After activation with IL 2-containing supernatants, mature T3+, T6- thymocytes proliferate and are able to nonspecifically kill different target cells. The activated thymocytes are T3+, T11+, T6-, OKM1- and bear T4 or T8 antigens in mutually exclusive cell subpopulations. They also "de novo" express the IL 2 receptor, and the 210.000/130.000 molecular complex defined by the TS2/7 MAb. Activated human thymocytes express higher amounts of class I and class II MHC antigens, equal T3 and LFA-1, and lower quantities of T11 and T4 molecules than nonactivated thymocytes. Furthermore, activated thymocytes only express the T8 34,000 dalton polypeptide subunit, whereas the nonactivated thymocyte population expressed the T8 34,000 dalton associated with a 46,000 glycoprotein. We have demonstrated that this structural change in the T8 molecule from a complex of two polypeptide subunits of 46,000 and 32,000 does not indeed occur in the activation process but rather in the maturation from T6+ to T6- thymocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415591

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes.

Authors:  L L Lanier; J H Phillips
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

2.  Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.

Authors:  P Sánchez-Mateos; M Cebrián; A Acevedo; M López-Botet; M O De Landázuri; F Sánchez-Madrid
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

3.  ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells.

Authors:  Beatriz G Gálvez; Salomón Matías-Román; María Yáñez-Mó; Francisco Sánchez-Madrid; Alicia G Arroyo
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

4.  Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells.

Authors:  A Acevedo; M A del Pozo; A G Arroyo; P Sánchez-Mateos; R González-Amaro; F Sánchez-Madrid
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

5.  Dexamethasone modifies the functional responses of the granulocytic differentiating HL-60 cells.

Authors:  D Collado-Escobar; F Mollinedo
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  JL1, a novel differentiation antigen of human cortical thymocyte.

Authors:  S H Park; Y M Bae; H J Kwon; T J Kim; J Kim; S J Lee; S K Lee
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

7.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.

Authors:  M Cebrián; E Yagüe; M Rincón; M López-Botet; M O de Landázuri; F Sánchez-Madrid
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.